Skip to content

FP7H2020HORIZON

Turun Yliopisto

Country
FIFinland
Defence projects
0
Projects, all programmes
231
As coordinator
65
EU contribution (CORDIS)
EUR 109,096,252
Active
2008 to 2026

Projects

231 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
EbolaMoDRADEbola Virus: Modern Approaches for developing bedside Rapid Diagnostics – Sofia ref.: 115843H20202015ParticipantEUR 115,000
BALaNCEBreAking the Link betweeN myo10 and CancErH20202015CoordinatorEUR 150,000
QuProCSQuantum Probes for Complex SystemsH20202015CoordinatorEUR 580,000
ENLIGHT-TENEuropean Network linking informatics and genomics of helper T cellsH20202015ParticipantEUR 269,145
ALMARVIAlgorithms, Design Methods, and Many-Core Execution Platform for Low-Power Massive Data-Rate Video and Image ProcessingFP72014ParticipantEUR 207,080
BM4SITAN INNOVATIVE CAUSAL THERAPY FOR ALLERGY: SAFE AND RAPID INDUCTION OF AN ANTI-INFLAMMATORY IMMUNE RESPONSE USING A MUTANT HYPOALLERGEN AND VITAMIN D3FP72014ParticipantEUR 287,700
GBX IN FISH RBCSExpression and function of globin X in nucleated red blood cells of fishH20202014CoordinatorEUR 276,865
ADHESWITCHESAdhesion switches in cancer and development: from in vivo to synthetic biologyFP72014CoordinatorEUR 1,887,910
ARK OF INQUIRYArk of Inquiry: Inquiry Awards for Youth over EuropeFP72014ParticipantEUR 277,260
INDIRECTIntergenerational Cumulative Disadvantage and Resource CompensationFP72014CoordinatorEUR 1,880,328
BETACUREPersonalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathologyFP72014ParticipantEUR 250,000
AIROPICOAcademia-Industry Research and Development Opportunities for PicornavirusesH20202014ParticipantEUR 134,792
MNEMERGEA Framework Model on MNE’s impact on global development challenges in emerging marketsFP72014ParticipantEUR 212,080
TUMADORDevelopment of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancersFP72013ParticipantEUR 781,675
CARDIMMUNA new therapeutic antibody with a personalised medicine approach in cardiovascular diseaseFP72013ParticipantEUR 122,760
EUROCLASTExploring Functional and Developmental Osteoclast Heterogeneity in Health and DiseaseFP72013ParticipantEUR 266,698
CALIPSOCalcium- and light signals in photosynthetic organismsFP72013ParticipantEUR 291,998
R'BIRTHBrain Imaging Return to HealthFP72013ParticipantEUR 324,400
PORTOPIAPorts Observatory for Performance Indicator AnalysisFP72013ParticipantNot stated
BALTICFLOWSMonitoring and management of flowing rain water in Baltic Sea catchment areasFP72013CoordinatorEUR 312,448

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.